Cargando…
A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice
Vaccination is an effective strategy to control influenza disease. Adjuvants enhance the efficacy of vaccines, but few adjuvants are approved for human use, so novel, safe, and effective adjuvants are urgently needed. The glycolipid adjuvant 7DW8-5 has shown adjuvanticity to malaria vaccine; however...
Autores principales: | Feng, Huapeng, Nakajima, Noriko, Wu, Li, Yamashita, Makoto, Lopes, Tiago J. S., Tsuji, Moriya, Hasegawa, Hideki, Watanabe, Tokiko, Kawaoka, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759631/ https://www.ncbi.nlm.nih.gov/pubmed/31620111 http://dx.doi.org/10.3389/fmicb.2019.02157 |
Ejemplares similares
-
Injectable Excipients as Novel Influenza Vaccine Adjuvants
por: Feng, Huapeng, et al.
Publicado: (2019) -
Food Additives as Novel Influenza Vaccine Adjuvants
por: Feng, Huapeng, et al.
Publicado: (2019) -
A Glycolipid α-GalCer Derivative, 7DW8-5 as a Novel Mucosal Adjuvant for the Split Inactivated Influenza Vaccine
por: Feng, Huapeng, et al.
Publicado: (2022) -
Identification of Novel Adjuvants for Ebola Virus-Like Particle Vaccine
por: Feng, Huapeng, et al.
Publicado: (2020) -
Sex-Specific Differences in Cytokine Induction by the Glycolipid Adjuvant 7DW8-5 in Mice
por: Watson, Felicia N., et al.
Publicado: (2022)